News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
845,445 Results
Type
Article (86430)
Company Profile (702)
Press Release (758313)
Multimedia
Podcasts (129)
Webinars (14)
Section
Business (232648)
Career Advice (4126)
Deals (39715)
Drug Delivery (129)
Drug Development (90972)
Employer Resources (198)
FDA (18097)
Job Trends (17328)
News (396400)
Policy (39738)
Tag
2024 BioCapital Digital (20)
2024 BioForest Digital (16)
2024 BioForest Standard (1)
2024 BioMidwest Digital (14)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (19)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (20)
2024 Biotech Beach Digital (15)
2024 Biotech Beach Standard (9)
2024 Genetown Digital (10)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (17)
2024 Pharm Country Digital (13)
2024 Pharm Country Standard (6)
2025 BioForest Digital (13)
2025 Lone Star Bio Digital (16)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (2)
Academia (3000)
Academic (2)
Accelerated approval (6)
Adcomms (29)
Allergies (92)
Alliances (56815)
ALS (99)
Alzheimer's disease (1496)
Antibody-drug conjugate (ADC) (156)
Approvals (18061)
Artificial intelligence (318)
Autoimmune disease (29)
Automation (16)
Bankruptcy (405)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (119)
Biotechnology (481)
Bladder cancer (81)
Brain cancer (31)
Breast cancer (296)
Cancer (2363)
Cardiovascular disease (201)
Career advice (3532)
Career pathing (34)
CAR-T (167)
Cell therapy (474)
Cervical cancer (21)
Clinical research (73328)
Collaboration (894)
Compensation (541)
Complete response letters (30)
COVID-19 (2863)
CRISPR (45)
C-suite (255)
Cystic fibrosis (107)
Data (2189)
Decentralized trials (2)
Denatured (45)
Depression (54)
Diabetes (291)
Diagnostics (6912)
Digital health (20)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (152)
Drug pricing (126)
Drug shortages (33)
Duchenne muscular dystrophy (101)
Earnings (96464)
Editorial (43)
Employer branding (25)
Employer resources (167)
Events (129718)
Executive appointments (754)
FDA (19388)
Featured Employer (64)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (809)
Gene editing (115)
Generative AI (35)
Gene therapy (343)
GLP-1 (848)
Government (5154)
Grass and pollen (6)
Guidances (53)
Healthcare (20884)
Huntington's disease (25)
IgA nephropathy (29)
Immunology and inflammation (143)
Indications (29)
Infectious disease (3024)
Inflammatory bowel disease (150)
Inflation Reduction Act (11)
Influenza (57)
Intellectual property (98)
Interviews (812)
IPO (17807)
IRA (51)
Job creations (5187)
Job search strategy (2861)
Kidney cancer (11)
Labor market (42)
Layoffs (550)
Leadership (22)
Legal (10113)
Liver cancer (79)
Lung cancer (337)
Lymphoma (154)
Machine learning (6)
Management (65)
Manufacturing (344)
MASH (73)
Medical device (14622)
Medtech (14627)
Mergers & acquisitions (22432)
Metabolic disorders (774)
Multiple sclerosis (84)
NASH (23)
Neurodegenerative disease (109)
Neuropsychiatric disorders (34)
Neuroscience (2083)
NextGen: Class of 2025 (7682)
Non-profit (5078)
Northern California (2675)
Now hiring (40)
Obesity (419)
Opinion (274)
Ovarian cancer (76)
Pain (95)
Pancreatic cancer (84)
Parkinson's disease (159)
Partnered (24)
Patents (245)
Patient recruitment (109)
Peanut (51)
People (65242)
Pharmaceutical (143)
Pharmacy benefit managers (21)
Phase I (22620)
Phase II (31830)
Phase III (23997)
Pipeline (1194)
Policy (167)
Postmarket research (3552)
Preclinical (10179)
Press Release (72)
Prostate cancer (106)
Psychedelics (38)
Radiopharmaceuticals (269)
Rare diseases (424)
Real estate (7392)
Recruiting (75)
Regulatory (26755)
Reports (57)
Research institute (2657)
Resumes & cover letters (649)
Rett syndrome (4)
RNA editing (4)
RSV (50)
Schizophrenia (78)
Series A (142)
Series B (89)
Service/supplier (30)
Sickle cell disease (58)
Southern California (2318)
Special edition (18)
Spinal muscular atrophy (166)
Sponsored (34)
Startups (4290)
State (2)
Stomach cancer (16)
Supply chain (75)
Tariffs (38)
The Weekly (82)
United States (24145)
Vaccines (802)
Venture capitalists (44)
Weight loss (301)
Women's health (40)
Worklife (19)
Date
Today (85)
Last 7 days (755)
Last 30 days (2503)
Last 365 days (35826)
2025 (10984)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1271)
Alabama (59)
Alaska (7)
Arizona (267)
Arkansas (14)
Asia (50097)
Australia (8824)
California (6249)
Canada (2017)
China (549)
Colorado (279)
Connecticut (294)
Delaware (153)
Europe (114854)
Florida (910)
Georgia (216)
Hawaii (1)
Idaho (64)
Illinois (614)
India (31)
Indiana (330)
Iowa (12)
Japan (164)
Kansas (109)
Kentucky (27)
Louisiana (14)
Maine (70)
Maryland (946)
Massachusetts (4805)
Michigan (243)
Minnesota (414)
Mississippi (2)
Missouri (92)
Montana (31)
Nebraska (26)
Nevada (65)
New Hampshire (69)
New Jersey (1777)
New Mexico (31)
New York (1772)
North Carolina (1113)
North Dakota (8)
Northern California (2675)
Ohio (214)
Oklahoma (15)
Oregon (48)
Pennsylvania (1381)
Puerto Rico (12)
Rhode Island (35)
South America (1652)
South Carolina (23)
South Dakota (1)
Southern California (2318)
Tennessee (104)
Texas (940)
Utah (188)
Virginia (168)
Washington D.C. (69)
Washington State (597)
West Virginia (3)
Wisconsin (66)
There are 845,445 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BlackfinBio Announces FDA Clearance to Initiate Phase 1/2 Clinical Trial for Novel AAV Gene Therapy BFB-101 to Treat the Rare Neurological Disease Hereditary Spastic Paraplegia, Type 47 (SPG47)
April 28, 2025
·
4 min read
Press Releases
BEYONTTRA® (acoramidis), the First Near-complete TTR Stabilizer (≥90%), Approved by the UK Medicines and Healthcare Products Regulatory Agency to Treat ATTR-CM
April 28, 2025
·
10 min read
Press Releases
Portage Biotech Reports Confirmatory Preclinical Results in Mesothelioma Supporting First-In-Human Trial of PORT-7
April 28, 2025
·
3 min read
Press Releases
IDEAYA Biosciences to Participate in Upcoming May 2025 Investor Relations Events
April 28, 2025
·
2 min read
Press Releases
Metrion Biosciences Launches Nav1.9 High-Throughput Screening Assay to Strengthen Screening Portfolio and Advance Research on New Medicines for Pain
April 28, 2025
·
3 min read
Press Releases
argenx Announces Positive CHMP Opinion for VYVGART (efgartigimod alfa) Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
April 28, 2025
·
8 min read
Press Releases
BioVersys to Host Virtual KOL Event to Discuss BV100 Phase 2 Ventilator Associated Pneumonia (VABP) Study Against Carbapenem Resistant Acinetobacter on May 7, 2025
April 28, 2025
·
4 min read
Press Releases
YolTech Announces First Clinical Data from Ongoing Investigator-Initiated Trial of YOLT-101, An In-Vivo Base Editing Therapy for Familial Hypercholesterolemia
April 28, 2025
·
7 min read
Press Releases
Purespring Therapeutics granted European Medicines Agency (EMA) orphan drug designation for PS-002 for the treatment of patients with primary IgA nephropathy (IgAN)
April 28, 2025
·
4 min read
Press Releases
LIfT BioSciences announces partnership with University of Galway for clinical trial in Ireland
April 28, 2025
·
4 min read
1 of 84,545
Next
